Ohlbe
★★★

France,
2020-04-29 01:01
(1896 d 10:48 ago)

Posting: # 21358
Views: 3,534
 

 FDA recommendations on BE trials during the pandemic [Regulatives / Guidelines]

Dear all,

The FDA has published high-level recommendations on bioequivalence studies for submission in ANDAs during the COVID-19 pandemic. Basically: it may be a mess outside (no kidding !), prioritise subjects' safety, use controlled correspondence.

Regards
Ohlbe
UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,692 registered users;
89 visitors (0 registered, 89 guests [including 12 identified bots]).
Forum time: 11:49 CEST (Europe/Vienna)

Anyone who conducts an argument by appealing to authority
is not using his intelligence;
he is just using his memory.    Leonardo da Vinci

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5